Validation of the IPF-specific version of St. George’s Respiratory Questionnaire-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validation of the IPF-specific version of St. George’s Respiratory Questionnaire

Published:2019-08-28 Issue:1 Volume:20 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Prior Thomas Skovhus^ORCID,Hoyer Nils,Shaker Saher Burhan,Davidsen Jesper Rømhild,Yorke Janelle,Hilberg Ole,Bendstrup Elisabeth

Funder

TrygFonden

Aarhus University

Boehringer Ingelheim Denmark

The Danish Lung Association’s Fund

The Health Research Fund of the Central Denmark Region

The Ellen and Knud Dalhoff Larsen’s Fund

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s12931-019-1169-9.pdf

Reference32 articles.

1. Raghu G, Chen S-Y, Yeh W-S, Maroni B, Li Q, Lee Y-C, et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11. Lancet Respir Med [Internet]. 2014;2600(14):1–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24875841 .

2. Belkin A, Swigris JJ. Health-related quality of life in idiopathic pulmonary fibrosis: where are we now? Curr Opin Pulm Med [Internet]. 2013 Sep [cited 2015 Nov 29];19(5):474–479. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23851327 .

3. Richeldi L, Cottin V, du Bois RM, Selman M, Kimura T, Bailes Z, et al. Nintedanib in patients with idiopathic pulmonary fibrosis: combined evidence from the TOMORROW and INPULSIS® trials. Respir Med [Internet] 2016; Available from: http://linkinghub.elsevier.com/retrieve/pii/S0954611116300191 .

4. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet (London, England) [Internet] 2011 May 21 [cited 2016 Feb 21];377(9779):1760–1769. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21571362 .

5. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med [Internet]. 1993 Apr 15 [cited 2015 Oct 15];118(8):622–629. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8452328 .

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the St. George’s respiratory questionnaire in idiopathic pulmonary fibrosis: a systematic review with meta-analysis of psychometric properties using COSMIN;Discover Social Science and Health;2024-07-02

2. Impact of Pirfenidone on Patient-Reported Outcomes in Patients With Idiopathic Pulmonary Fibrosis From the Pulmonary Fibrosis Foundation Patient Registry;CHEST Pulmonary;2024-07

3. Fibroblast activation protein and disease severity, progression, and survival in idiopathic pulmonary fibrosis;Scandinavian Journal of Immunology;2024-06-07

4. Divergent perspectives: exploring the relationships between St. George’s Respiratory Questionnaire and outcome measures in systemic sclerosis–associated interstitial lung disease;Clinical Rheumatology;2024-04-04

5. Efficacy and safety of Kangxian Huanji Granule as adjunctive treatment in acute exacerbation of idiopathic pulmonary fibrosis: An exploratory randomized controlled trial;Journal of Integrative Medicine;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3